Core Insights - ADMA Biologics, Inc. is focused on developing plasma-derived biologics and has three FDA-approved products, including Asceniv, which is effective against RSV [1] Company Overview - ADMA Biologics, Inc. operates in the biopharmaceutical sector, specializing in products derived from human plasma [1] - The company has a notable product, Asceniv, which is an RSV-enriched immunoglobulin, making it particularly suitable for treating respiratory syncytial virus infections [1]